{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:22:30Z","timestamp":1793816550963,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["2021M3H9A1097551"],"award-info":[{"award-number":["2021M3H9A1097551"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["2022M3A9B6082668"],"award-info":[{"award-number":["2022M3A9B6082668"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["2020R1A6A1A03043708"],"award-info":[{"award-number":["2020R1A6A1A03043708"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.redox.2023.102783","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T21:53:27Z","timestamp":1686866007000},"page":"102783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Development of KEAP1-targeting PROTAC and its antioxidant properties: In vitro and in vivo"],"prefix":"10.1016","volume":"64","author":[{"given":"Se Yong","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Gurung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ho","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alam","family":"Zeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ik","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Jean","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Joo","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3678-2772","authenticated-orcid":false,"given":"Seung Hyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2023.102783_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6175804","article-title":"ROS generation and antioxidant defense systems in normal and malignant cells","volume":"2019","author":"Snezhkina","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2023.102783_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112891","article-title":"Oxidative stress mitigation by antioxidants - an overview on their chemistry and influences on health status","volume":"209","author":"Pisoschi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.redox.2023.102783_bib3","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.redox.2023.102783_bib4","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3389\/fphar.2018.01428","article-title":"The role of Nrf2 in liver disease: novel molecular mechanisms and therapeutic approaches","volume":"9","author":"Xu","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.redox.2023.102783_bib5","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/cam4.2101","article-title":"Nrf2 in cancers: a double-edged sword","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.redox.2023.102783_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/ars.2008.2242","article-title":"The Nrf2\/ARE pathway as a potential therapeutic target in neurodegenerative disease","volume":"11","author":"Calkins","year":"2009","journal-title":"Antioxidants Redox Signal."},{"issue":"7","key":"10.1016\/j.redox.2023.102783_bib7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/14728220903025762","article-title":"Targeting the Nrf2 pathway against cardiovascular disease","volume":"13","author":"Li","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.redox.2023.102783_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2009.07.024","article-title":"Nrf2 protects against airway disorders","volume":"244","author":"Cho","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.redox.2023.102783_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s42826-022-00133-4","article-title":"Ventilator-induced lung injury results in oxidative stress response and mitochondrial swelling in a mouse model","volume":"38","author":"Joelsson","year":"2022","journal-title":"Lab Anim Res"},{"issue":"22","key":"10.1016\/j.redox.2023.102783_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.redox.2023.102783_bib11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.redox.2023.102783_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","article-title":"The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer","volume":"1","author":"Kansanen","year":"2013","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.redox.2023.102783_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1096\/fj.04-2591hyp","article-title":"Nrf2, a multi-organ protector?","volume":"19","author":"Lee","year":"2005","journal-title":"Faseb. J."},{"issue":"7","key":"10.1016\/j.redox.2023.102783_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/1061186X.2020.1870987","article-title":"The relevant targets of anti-oxidative stress: a review","volume":"29","author":"Qi","year":"2021","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.redox.2023.102783_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.14336\/AD.2018.0513","article-title":"The anti-inflammatory and anti-oxidant mechanisms of the Keap1\/Nrf2\/ARE signaling pathway in chronic diseases","volume":"10","author":"Tu","year":"2019","journal-title":"Aging Dis"},{"issue":"1","key":"10.1016\/j.redox.2023.102783_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.redox.2023.102783_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ddtec.2019.01.002","article-title":"PROteolysis TArgeting Chimeras (PROTACs) - past, present and future","volume":"31","author":"Pettersson","year":"2019","journal-title":"Drug Discov. Today Technol."},{"issue":"10","key":"10.1016\/j.redox.2023.102783_bib18","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.chembiol.2022.08.003","article-title":"Exploring the target scope of KEAP1 E3 ligase-based PROTACs","volume":"29","author":"Du","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.redox.2023.102783_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102552","article-title":"Design and characterization of a heterobifunctional degrader of KEAP1","volume":"59","author":"Chen","year":"2023","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.redox.2023.102783_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/acsptsci.2c00165","article-title":"Cell-permeable PROTAC degraders against KEAP1 efficiently suppress hepatic stellate cell activation through the antioxidant and anti-inflammatory pathway","volume":"6","author":"Wang","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"8","key":"10.1016\/j.redox.2023.102783_bib21","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","article-title":"Monoacidic inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein-protein interaction with high cell potency identified by fragment-based Discovery","volume":"59","author":"Davies","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.redox.2023.102783_bib22","first-page":"1","article-title":"Relationship between the proteasomal system and autophagy","volume":"4","author":"Lilienbaum","year":"2013","journal-title":"Int J Biochem Mol Biol"},{"key":"10.1016\/j.redox.2023.102783_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120111","article-title":"Nrf2\/Keap1\/ARE signaling: towards specific regulation","volume":"291","author":"Ulasov","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.redox.2023.102783_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56177-5","article-title":"Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.redox.2023.102783_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.redox.2023.102783_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-022-00453-5","article-title":"Use of analgesics\/antipyretics in the management of symptoms associated with COVID-19 vaccination","volume":"7","author":"Ooi","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"16","key":"10.1016\/j.redox.2023.102783_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.15585\/mmwr.mm7216a3","article-title":"Suspected suicide attempts by self-poisoning among persons aged 10-19 Years during the COVID-19 pandemic - United States, 2020-2022","volume":"72","author":"Farah","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.redox.2023.102783_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1742-4682-9-55","article-title":"The biochemistry of acetaminophen hepatotoxicity and rescue: a mathematical model","volume":"9","author":"Ben-Shachar","year":"2012","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.redox.2023.102783_bib29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/bs.apha.2019.01.007","article-title":"Acetaminophen hepatotoxicity: a mitochondrial perspective","volume":"85","author":"Ramachandran","year":"2019","journal-title":"Adv. Pharmacol."},{"issue":"3","key":"10.1016\/j.redox.2023.102783_bib30","first-page":"153","article-title":"Acetaminophen-induced liver injury: from animal models to humans","volume":"2","author":"Jaeschke","year":"2014","journal-title":"J Clin Transl Hepatol"},{"issue":"3\u20134","key":"10.1016\/j.redox.2023.102783_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.livres.2019.10.002","article-title":"Mitochondrial damage and biogenesis in acetaminophen-induced liver injury","volume":"3","author":"Jaeschke","year":"2019","journal-title":"Liver Res"},{"issue":"2","key":"10.1016\/j.redox.2023.102783_bib32","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update","volume":"4","author":"Yoon","year":"2016","journal-title":"J Clin Transl Hepatol"},{"issue":"12","key":"10.1016\/j.redox.2023.102783_bib33","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1016\/j.apsb.2021.09.023","article-title":"Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls","volume":"11","author":"Jaeschke","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.redox.2023.102783_bib34","doi-asserted-by":"crossref","first-page":"26087","DOI":"10.3390\/ijms161125942","article-title":"The role of oxidative stress and antioxidants in liver diseases","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2023.102783_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ddtec.2019.02.005","article-title":"Targeted protein degradation in vivo with Proteolysis Targeting Chimeras: current status and future considerations","volume":"31","author":"Watt","year":"2019","journal-title":"Drug Discov. Today Technol."},{"issue":"10","key":"10.1016\/j.redox.2023.102783_bib36","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.drudis.2020.07.013","article-title":"Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective","volume":"25","author":"Pike","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.redox.2023.102783_bib37","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jmedchem.5b01735","article-title":"A FRET-based assay for the identification and characterization of cereblon ligands","volume":"59","author":"Boichenko","year":"2016","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.redox.2023.102783_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jsb.2014.10.010","article-title":"Thalidomide mimics uridine binding to an aromatic cage in cereblon","volume":"188","author":"Hartmann","year":"2014","journal-title":"J. Struct. Biol."},{"issue":"23","key":"10.1016\/j.redox.2023.102783_bib39","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2023.102783_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100086","article-title":"Protocol for primary mouse hepatocyte isolation","volume":"1","author":"Charni-Natan","year":"2020","journal-title":"STAR Protoc"},{"issue":"7","key":"10.1016\/j.redox.2023.102783_bib41","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.redox.2023.102783_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113514","article-title":"Inhibitory effect of 20(S)-protopanaxadiol on cytochrome P450: potential of its pharmacokinetic interactions in vivo","volume":"153","author":"Lee","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.redox.2023.102783_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/nu12113585","article-title":"Allyl isothiocyanate protects acetaminophen-induced liver injury via NRF2 activation by decreasing spontaneous degradation in hepatocyte","volume":"12","author":"Kim","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.redox.2023.102783_bib44","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/nprot.2006.378","article-title":"Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method","volume":"1","author":"Rahman","year":"2006","journal-title":"Nat. Protoc."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723001842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723001842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:38:54Z","timestamp":1761979134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231723001842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":44,"alternative-id":["S2213231723001842"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2023.102783","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of KEAP1-targeting PROTAC and its antioxidant properties: In vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2023.102783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102783"}}